19th Annual Inflammatory Bowel Disease: The Art and Science in the Diagnosis and Treatment 2026

Boston, MA US
September 25, 2026 to September 26, 2026

Registration for IBD Boston 2026 is now open! September 25 to 26, 2026!

Each year, the Boston IBD conference  brings top gastroenterology specialists from North America together with up-and-coming Boston area specialists for a 1.5 day CE program. This program is designed to stimulate conversations about how to initiate practice changes within the IBD healthcare team in the diagnosis and management of patients with Crohn's disease (CD) and ulcerative colitis (UC).  Through keynote talks and panel discussions, you will be challenged to develop innovative strategies to improve the quality of life for your patients while prolonging clinical remission. The city of Boston provides an excellent backdrop for this educational and networking experience – we hope you can join us in person this year.

What past attendees have said about the Boston IBD Meeting:

  • Absolutely wonderful! Can't wait for next year!

  • This conference is such a gem and important resource for GI docs. This is a world class conference!

  • Excellent program very thoughtfully constructed!

  • Wonderful and as always highly educational! Provides useful information we can apply to our practice daily

Registration Fees
MD/DO$325
Allied Healthcare (RN, PA, NP)$250
Fellows/Resident/Student $100

BU Alumni are 20% off.  Please use coupon code ALUMNI20 at checkout

In conjunction with:

 
Boston Medical Center
Beth Israel Deaconess Medical Center
Brigham and Women’s Hospital
Boston Children’s Hospital
Lahey Hospital & Medical Center
Massachusetts General Hospital
Tufts Medical Center
UMass Memorial Medical Center
 

Target Audience

This course is designed for the entire IBD healthcare team including gastroenterologists, pediatric gastroenterologists, colorectal surgeons, NP/PAs, nurses. pharmacists and other health care professionals caring for patients with CD and UC.

 

Learning Objectives

At the conclusion of this activity, the learner or healthcare team, will be able to:

  1. Describe key recommendations from recent ACG/AGA inflammatory bowel disease (IBD) guidelines and how they inform precision, risk‑stratified care.
  2. Discuss the best practices for the diagnosis and treatment of mild Crohn’s disease and ulcerative colitis.
  3. Consider long-term management strategies and individualized care for patients with IBD..
  4. Assess efficacy and safety in newer agents that may be approved by regulatory agencies for the  treatment of IBD.
  5. Describe the range of alternative and complementary therapies used in IBD.
  6. Discuss recent updates in medical management of intermittent and chronic pouchitis.
  7. Apply current best practices for dysplasia surveillance in IBD, including optimal endoscopic techniques and surveillance intervals.
  8. Develop an evidence-based treatment plan for the diagnosis and treatment of fatigue in IBD patients.
  9. Describe the principles and clinical utility of intestinal ultrasound (IUS) and evaluate the role of IUS in diagnosis and baseline assessment of inflammatory bowel disease.
  10. Strategize how to address common calls from patients with IBD. 
  11. Recognize how to best use imaging studies to aid in with IBD diagnosis and management.
  12. Identify the role of dietary and nutritional interventions in the treatment of IBD. 
  13. Learn how application of knowledge from monogenic and very early onset IBD can translate into potential novel treatment approaches for more general IBD.
  14. Create and sustain an interprofessional team (e.g., gastroenterologists, pharmacists, nurses, advanced practice clinicians, dieticians) to support the care of patients with IBD.

 

Course summary
Available credit: 
  • 10.50 ABIM Medical Knowledge
  • 10.50 ABP Lifelong Learning and Self-Assessment
  • 10.50 ABS Accredited CME
  • 10.50 ACPE Pharmacy
  • 10.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 10.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 10.75 ANCC
    • 5.50 ANCC Pharmacology
  • 10.50 Participation
Course opens: 
03/30/2026
Course expires: 
11/06/2026
Event starts: 
09/25/2026 - 12:45pm EDT
Event ends: 
09/26/2026 - 4:00pm EDT
Cost:
$325.00
Friday, September 25, 2026  
  
12:00pmRegistration
  
12:45pmWelcome and Introduction
 Randy Pellish, MD 
  
12:50pmLessons from the Bench to the Bedside: Translating Pediatric IBD Discovery into Clinical Progress
 Scott Snapper, MD
  
1:35pmWomen’s issues in IBD - Pregnancy and Sexuality
 Loren Rabinowitz, MD
  
2:00pmManagement of Mild Inflammatory Bowel Diseases
 Ashwin Ananthakrishnan, MD
  
2:25pmPanel: Management of inpatient IBD - case based
 Moderator: Randy Pellish, MD
 Ashwin Ananthakrishnan, MD 
 Ed Barnes, MD
 Rachel Winter, MD
  
3:10pmComplementary and Alternative Therapies in IBD
 Samantha Zullow, MD
  
3:35pmBreak
  
3:55pmTherapeutic Positioning in IBD
 Adam Cheifetz, MD
  
4:40pmKeynote - Management of Pouchitis and Other Pouch-Related Disorders: Where Can We Go From Here?
 Ed Barnes, MD
  
5:15pmAdjourn
  
Saturday, September 26, 2026
  
7:30amRegistration and Breakfast
  
8:00amIntroduction 
  
8:05amkeynote - Prediction and Prevention of Inflammatory Bowel Disease
 Ryan Ungaro, MD
  
8:50amSurveillance and Management of IBDAssociated Dysplasia
 Kristin Burke, MD
  
9:15amFatigue in Children and Adults with IBD
 Athos Bousvaros, MD
  
9:40amPanel: Obtaining Access to Medically Necessary Medications in IBD
 Moderator: Jeremy Spiewak, PharmD, MCSR-RPh, MSCS
 Jess Kaplan, MD
 Brittany Ross, PharmD, BCPS, BCPPS
 Jacqui Danis, NP
  
10:25amBreak  
  
10:45amPanel: Severe Perianal Disease
 Moderator: Abbas Rupawala, MD
 Lilian Chen, MD 
 Ryan Ungaro, MD
 Paul Rufo, MD
  
11:30amThe Evolving Role of Intestinal Ultrasound in Inflammatory Bowel Disease Management
 Arushi Kohli, MD
  
11:55amPanel: Post Operative Crohn’s Management, Multidisciplinary Real World Case Discussions
 Moderator: Sean Fine, MD
 Olga Beresneva, MD 
 Jim Lewis, MD
 Chris Moran, MD
 Cailtin Phinney, MSN, RN, FNP-BC
  
12:35pmLunch
  
1:20pmKeynote - Evolving Thoughts on Diet in the Management of IBD
 Jim Lewis, MD
  
2:05pmAbdominal Imaging for the Diagnosis and Management of Inflammatory Bowel Disease 
 Avneesh Gupta, MD
 Matt Hamilton, MD
  
2:30pmPanel: Common Themes for Phone Triage - What to Do?
 Moderator: Laurie Grossberg, MD
 Caitlin Dolan, MS, BSN, FNP-BC
 Jay Fong, MD
 Sushrut Jangi, MD
  
2:55pmTop Articles in IBD
 Vanessa Mitsilais, MD 
 Sharmeel Wasan, MD
  
3:40pmAdjourn
  
  
  
Agenda subject to change without notice
  
  
Revere Hotel Boston Common
200 Stuart Street
Silver Ballroom
Boston, MA 02116
United States
+1 (617) 482-1800

A block of rooms has been reserved starting at the special rate of $399/night, single or double, plus applicable taxes. The room block will be held until September 3. 2026, or until it is full.  Space is limited and is subject to availability.  You may make reservations online. 

Please visit this link to make your reservation - IBD Room Block

By staying at the conference venue, you help the host organizations meet their contractual obligations. Please take this into consideration when making your accommodation decision.  Thank you!

Travel

Transportation

Logan International Airport (BOS) is 7 miles from the Revere Hotel Boston Common (15 – 30 minutes driving, depending on traffic).

Logan Airport offers passengers a variety of transportation options ranging from taxi and limousine services to rental cars and shuttle buses plus connections to local bus and train stations.  Visit http://www.massport.com/logan-airport/to-from-logan/transportation-options/ for more information.

Taxi Service
There are a number of taxi services available at Logan International Airport. The estimated fare to the Revere Hotel Boston Common is $35 – $65

Subway Service (MBTA Green Line)
Subway service is available from Logan International Airport to Revere Hotel Boston Common via the Blue Line to the Green Line (Arlington). The cost is $2.75. Visit  http://www.mbta.com for a schedule and details.

Note: Fares are subject to change.

Travel

Tourist Information
Boston's history recalls revolution and transformation, and today the city is still among the country’s most forward-thinking and barrier-breaking cities.  It is rich with history, culture and art.  Visit https://www.boston.gov/visiting-boston for more information.

Climate in September
Temperatures can range from 50° to 80°F.

Since everyone has a different level of comfort, we suggest you dress in layers.

 

 

Keynote Speakers
 
Edward L. Barnes, MD, MPH
Associate Professor of Medicine
Director, Gastroenterology and Hepatology Fellowship Program
Co-Director, Multidisciplinary Inflammatory Bowel Diseases Center
Director for Clinical Research, Multidisciplinary Inflammatory Bowel Diseases Center
Division of Gastroenterology and Hepatology
University of North Carolina at Chapel Hill
 
James D. Lewis, MD, MSCE
Professor of Medicine and Epidemiology
Chief of Gastroenterology Penn Presbyterian Medical Center
Vice-Chief for Research, Division of Gastroenterology and Hepatology
Senior Scholar, Center for Clinical Epidemiology and Biostatistics
Perelman School of Medicine, University of Pennsylvania
 
Ryan Ungaro, MD MS
Associate Professor of Medicine
Director of Clinical Research, Division of Gastroenterology 
Icahn School of Medicine at Mount Sinai
 
Speakers
 
Olga Beresneva, MD
Colon and Rectal Surgeon
Department of Surgery, Boston Medical Center
Assistant Professor of Surgery, Boston University Chobanian & Avedisian School of Medicine
 
Jacqui Danis, NP
Lahey Hospital & Medical Center
 
Caitlin Dolan, MS, BSN, FNP-BC
APRN Director
Clinical Research Center, Infusion Center, Vascular Access
Service, & Ambulatory Allergy, Gastroenterology,
Immunology, Infectious Disease, Pulmonary,
Rheumatology, & Sleep Medicine 
Center for Inflammatory Bowel Disease and
Department of Gastroenterology and Nutrition
 
Jacqui Danis, NP
Gastroenterology
Lahey Hospital & Medical Center
 
Sean Fine MD, MS, FACG
Director, Inflammatory Bowel Disease Center
Assistant Professor of Medicine
Warren Alpert Medical School of Brown University
 
Avneesh Gupta, MD
Clinical Professor, Boston University Chobanian & Avedisian School of Medicine
 
Sushrut Jangi, MD
Assistant Professor, Tufts University School of Medicine
 
Jess Kaplan, MD
Clinical Director, Pediatric Inflammatory Bowel Disease Program
Clinical Lead, Pediatric Fecal Microbiota Transplantation
Assistant Professor of Pediatrics, Harvard Medical School
 
Arushi Kohli, MD
Director of Intestinal Ultrasound Program, Tufts Medical Center
Assistant Professor, Tufts University School of Medicine
 
Vanessa Mitsialis, MD
Assistant Professor of Medicine, Harvard Medical School
Physician, Division of Gastroenterology, Hepatology and Endoscopy
Brigham and Women's Hospital
Researcher, Division of Gastroenterology, Hepatology and Nutrition
Boston Children's Hospital
 
Caitlin Phinney MSN, RN, FNP-BC
Family Nurse Practitioner, Level II APN
Department of Surgery
IBD/MUSIC program
Boston Children’s Hospital
 
Loren Rabinowitz, MD
Assistant Professor of Medicine, Harvard Medical School
Attending Physician, Gastroenterology, Beth Israel Deaconess Medical Center
 
Abbas Rupawala, MD
Director, Inflammatory Bowel Diseases Center
Assistant Professor, UMass Chan Medical School
UMass Memorial Medical Center
 
Rachel Winter, MD, MPH
Assistant Professor of Medicine, Harvard Medical School
Gastroenterology, Hepatology and EndoscopyInternal Medicine
 
Planning Committee/Speakers
 
Ashwin N Ananthakrishnan, MD, MPH
Associate Professor of Medicine
Director, Crohn’s and Colitis Center
Massachusetts General Hospital
 
Athos Bousvaros, MD, MPH
Course Co-Director
Professor of Pediatrics, Harvard Medical School
Associate Director
IBD Center Associate Chief, Division of Gastroenterology
Boston Children’s Hospital
 
Kristin E. Burke, MD, MPH
Medical Director of Quality, AMC Division of Gastroenterology, Hepatology, and Endoscopy, Mass General Brigham
Inflammatory Bowel Disease Physician, MGH Crohn’s and Colitis Center
Assistant Professor of Medicine, Harvard Medical School
 
Adam S. Cheifetz, MD
Director, Center for Inflammatory Bowel Disease
Medical Director, Infusion Services
Beth Israel Deaconess Medical Center
Professor of Medicine, Harvard Medical School
 
Lillian Chen, MD
Program Director, General Surgery Residency Program
Chief, Division of Colon & Rectal Surgery
Department of Surgery
Tufts Medical Center
 
Susan Dybowski, NP
CNE Course Advisor
Division of Gastroenterology, Hepatology and Nutrition
Boston Children’s Hospital
 
Jay Fong, MD, FAAP
Co-Chair, AAPI Employee Resource Group
Massachusetts Chapter AAP -Region 4 Representative
Pediatric Gastroenterology and Nutrition
UMass Memorial Children's Medical Center
 
Laurie B. Grossberg, MD
Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center 
Assistant Professor of Medicine, Harvard Medical School 
 
Matthew J. Hamilton, MD
Assistant Professor, Harvard Medical School
Gastroenterology, Hepatology and Endoscopy
 
Christopher J. Moran, MD
Assistant Professor of Pediatrics, Harvard Medical School
Research Director, Mass General for Children Pediatric IBD Program
Program Director, Mass General for Children's Pediatric GI Fellowship
 
Randall Pellish, MD
Chair, Division of Gastroenterology
Director, Lahey Inflammatory Bowel Disease Center
Associate Professor of Medicine, UMass Chan-Lahey, UMass Chan Medical School
Lahey Hospital and Medical Center, Beth Israel Lahey Health
 
Brittany Ross, MS, PharmD, BCPS, BCPPS
Pharmacy Course Advisor
Gastroenterology CDTM Pharmacist
Department of Pharmacy
Boston Children's Hospital
 
Paul Rufo, MD, MMSc
Assistant Professor of Pediatrics, Harvard Medical School
Program Director, Harvard Fellowship in Pediatric Gastroenterology
Boston Children’s Hospital
  
Scott B. Snapper, MD, PhD
Chief, Division of Gastroenterology, Hepatology, and Nutrition
Wolpow Family Chair and Director, Inflammatory Bowel Disease Center, Boston Children's Hospital
Physician, Crohn’s and Colitis Center, Division of Gastroenterology, Brigham and Women’s Hospital
Egan Family Foundation Professor of Pediatrics in the Field of Transitional Medicine & Professor of Medicine, Harvard Medical School
 
Jeremy KW Spiewak, PharmD, MCSR-RPh, MSCS
Ambulatory Clinical Pharmacy Specialist, Gastroenterology
Collaborative Practice Pharmacist – IBD
Beth Israel Lahey
Beth Israel Deaconess Medical Center
 
Sharmeel Kaur Wasan, MD
Course Co-Director
Clinical Associate Professor of Medicine
Boston University Chobanian and Avedisian School of Medicine
Gastroenterology Fellowship Program Director
Boston Medical Center
 
Samantha Zullow, MD
Course Co-Director
Inflammatory Bowel Disease Center
Beth Israel Deaconess Medical Center
Harvard Medical School

 

 

 

 
 
CCE Program Manager: Naomi Moeller

Credit Types:  CME, CNE, CPE


In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

 

Physicians
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nursing Contact Hours:
10.75 of which TBD are eligible for pharmacology credit

Pharmacy
This activity is approved for 10.5 CPE credit(s).

MOC

ABIM
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABP
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 10.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

ABS
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the various boards. 

ABS
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the various boards. 

Other Learners:  All other learners may claim a certificate of participation.  Consult your professional licensing board regarding the applicability and acceptance of certificates of participation for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Available Credit

  • 10.50 ABIM Medical Knowledge
  • 10.50 ABP Lifelong Learning and Self-Assessment
  • 10.50 ABS Accredited CME
  • 10.50 ACPE Pharmacy
  • 10.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 10.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 10.75 ANCC
    • 5.50 ANCC Pharmacology
  • 10.50 Participation

Price

Cost:
$325.00
Please login or register to take this course.

Please contact [email protected] with any questions.

Cancellation Policy
Substitutions may be made at any time without an additional charge. Refunds, less an $50 administrative fee, will be issued for all cancellations received two weeks prior to the start of the meeting. Should cancellation occur within the two-week window, a credit will be issued, not a refund. Credits will be honored for up to two years. “No shows” are subject to the full course fee. Cancellations/substitution(s) must be made in writing. Refunds or credits will not be issued once the conference has started. This course is subject to change or cancellation.  

If you need to cancel your registration, please click here

Special Services / Dietary Needs

Boston University strives to be accessible, inclusive and diverse in our facilities, programming and academic offerings. Your experience in this event is important to us. If you have a disability, require communication access services for the deaf or hard of hearing, or believe that you require a reasonable accommodation for another reason please contact the BU-CCE Office at least 3 weeks prior to event to discuss your needs.  For in person meetings with meals, we will work to accommodate dietary requests (including, but not limited to: kosher, vegetarian, low cholesterol, and low sodium) received in writing at least three weeks prior to the start of the conference.  Please contact us at [email protected]

Sharing Your Information Through Participant Lists:

If you checked "Yes" to sharing your information on the participant list, we only share name, degree, organization, city and state. Checking "Yes" indicates we may share your name with exhibitors from commercial entities (ineligible companies) including pharmaceutical and medical device companies.

Please Note

The conference organizers may take pictures or record videos during the conference. In registering for the conference, you acknowledge that BU-CCE may photograph you during the meeting, and you agree that we may include images of yourself, intact or in part, for conference promotional activities or other related endeavors. This material may also appear on the conference's website or associated social media outlets. If you do not wish to be photographed, please let the BUSM representative onsite know

Our COVID-19 Safety Precautions are as follows

We are committed to creating a safe conference environment. Mask-wearing is not required, but remains optional, for events. We also strongly encourage all attendees to be vaccinated with boosters, as eligible. Any participant with symptoms that could be related to COVID-19 should not engage in group activities and seek medical advice. 

We will continue to follow local, state, and Federal event and meeting protocols to ensure the health and safety of all attendees, staff, and the local community and will update all attendees on these protocols as we get closer to the meeting date

Unauthorized Registration Sites

Registration for courses managed by BU-CME can only be completed through our website at https://cme.bu.edu. Course registrations made through other sites cannot be honored. BUSM-CME is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com

Please report any unauthorized websites or solicitations for registrations to [email protected].

Boston University Chobanian & Avedisian School of Medicine seeks to ensure equitable treatment of every person and to make every attempt to resolve grievances in a fair manner. Please submit a written grievance to:   [email protected]617-358-5005.  Grievances would receive, to the best of our ability, corrective action in order to prevent further problems.